Last deal

$7.3M

Amount

Series A

Stage

09.10.2023

Date

2

all rounds

$13.3M

Total amount

General

About Company
Pixelgen Technologies develops technologies for biomedical research and diagnostics.

Industry

Sector :

Subsector :

Keywords :

founded date

01.01.2020

Number of employees

Last funding type

Series A

IPO status

Private

Description

Founded in 2020, Pixelgen Technologies is a Swedish-based company that provides bio-analytical tools for biomedical research and diagnostics. The company's mission is to bring a new spatial understanding to biology by developing tools that facilitate the mapping of cell surface proteins and their spatial inter-relationships. Pixelgen's Molecular Pixelation technology allows researchers to measure hundreds of proteins simultaneously and obtain the spatial mapping of these proteins on the cell surface, providing valuable insights into cellular activity and ultimately improving health. With a team of passionate and experienced innovators and entrepreneurs, Pixelgen is committed to advancing biomedicine through novel analytical methods and products.
Contacts

Social url